Regenerx Biopharmaceuticals Inc (RGRX)
0.0014
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Regenerx Biopharmaceuticals EPS Diluted (TTM): -0.904 for March 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -0.904 |
| December 31, 2022 | -0.9311 |
| September 30, 2022 | -0.9311 |
| June 30, 2022 | -0.9753 |
| March 31, 2022 | -0.8484 |
| December 31, 2021 | -0.8373 |
| September 30, 2021 | -0.8373 |
| June 30, 2021 | -0.787 |
| March 31, 2021 | -0.8605 |
| December 31, 2020 | -0.8667 |
| September 30, 2020 | -0.8667 |
| June 30, 2020 | -0.8713 |
| March 31, 2020 | -0.8404 |
| December 31, 2019 | -0.8701 |
| September 30, 2019 | -1.870 |
| June 30, 2019 | -1.922 |
| March 31, 2019 | -1.934 |
| December 31, 2018 | -2.613 |
| September 30, 2018 | -0.3765 |
| June 30, 2018 | -1.071 |
| March 31, 2018 | -0.6687 |
| December 31, 2017 | 0.4181 |
| September 30, 2017 | -0.4236 |
| June 30, 2017 | 1.576 |
| March 31, 2017 | 3.482 |
| Date | Value |
|---|---|
| December 31, 2016 | 0.3952 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -2.00 |
| March 31, 2016 | -6.00 |
| December 31, 2015 | -5.00 |
| September 30, 2015 | -6.00 |
| June 30, 2015 | -4.885 |
| March 31, 2015 | -3.121 |
| December 31, 2014 | -4.121 |
| September 30, 2014 | -3.121 |
| June 30, 2014 | -3.235 |
| March 31, 2014 | -3.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -1.00 |
| September 30, 2012 | -2.00 |
| June 30, 2012 | -5.00 |
| March 31, 2012 | -7.00 |
| December 31, 2011 | -8.00 |
| September 30, 2011 | -8.00 |
| June 30, 2011 | -7.00 |
| March 31, 2011 | -7.00 |
| December 31, 2010 | -7.00 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-1.922
Minimum
Jun 2019
-0.787
Maximum
Jun 2021
-1.001
Average
-0.8684
Median
EPS Diluted (TTM) Benchmarks
| FluoroPharma Medical Inc | -0.0867 |
| RenovaCare Inc | -0.0646 |
| Xeno Transplants Corp | -- |
| Entia Biosciences Inc | -0.05 |
| OncoVista Innovative Therapies Inc | -0.1423 |